KEGG   PATHWAY: uah05206
Entry
uah05206                    Pathway                                
Name
MicroRNAs in cancer - Ursus arctos horribilis (North American brown bear)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
Pathway map
uah05206  MicroRNAs in cancer
uah05206

Organism
Ursus arctos horribilis (North American brown bear) [GN:uah]
Gene
113258976  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
113257870  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
113256020  TIMP3; metalloproteinase inhibitor 3 [KO:K16866]
113257792  KRAS; GTPase KRas isoform X1 [KO:K07827]
113259981  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
113256823  CDC25A; M-phase inducer phosphatase 1 isoform X1 [KO:K06645] [EC:3.1.3.48]
113258383  CDC25B; M-phase inducer phosphatase 2 isoform X1 [KO:K05866] [EC:3.1.3.48]
113261495  CDC25C; LOW QUALITY PROTEIN: M-phase inducer phosphatase 3 [KO:K05867] [EC:3.1.3.48]
113256316  HMGA2; high mobility group protein HMGI-C [KO:K09283]
113243982  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
113258003  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
113252919  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
113244704  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
113247057  CRKL; crk-like protein [KO:K04438]
113269112  CRK; adapter molecule crk isoform X1 [KO:K04438]
113249825  HDAC4; histone deacetylase 4 isoform X1 [KO:K11406] [EC:3.5.1.98]
113265365  HDAC5; histone deacetylase 5 isoform X1 [KO:K11406] [EC:3.5.1.98]
113257079  FOXP1; forkhead box protein P1 isoform X1 [KO:K23582]
113243874  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
113263211  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
113270642  DNMT3A; DNA (cytosine-5)-methyltransferase 3A [KO:K17398] [EC:2.1.1.37]
113258482  DNMT3B; DNA (cytosine-5)-methyltransferase 3B isoform X1 [KO:K17399] [EC:2.1.1.37]
113246198  MCL1; induced myeloid leukemia cell differentiation protein Mcl-1 [KO:K02539]
113246084  BCL2L2; bcl-2-like protein 2 [KO:K02163]
113257444  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
113261040  VEGFA; vascular endothelial growth factor A [KO:K05448]
113244240  ZEB1; zinc finger E-box-binding homeobox 1 isoform X1 [KO:K09299]
113268733  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
113259607  EZR; LOW QUALITY PROTEIN: ezrin [KO:K08007]
113251928  PDCD4; programmed cell death protein 4 [KO:K16865]
113241737  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
113270858  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
113269709  TPM1; tropomyosin alpha-1 chain isoform X1 [KO:K10373]
113251451  SPRY2; protein sprouty homolog 2 isoform X1 [KO:K17383]
113253490  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
113253498  SERPINB5; serpin B5 [KO:K10139]
113259860  ST14; suppressor of tumorigenicity 14 protein [KO:K08670] [EC:3.4.21.109]
113241453  cytochrome P450 1B1 [KO:K07410] [EC:1.14.14.1]
113270510  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
113244532  RPTOR; regulatory-associated protein of mTOR [KO:K07204]
113258741  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial [KO:K07436] [EC:1.14.15.16]
113265512  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
113256440  ERBB3; receptor tyrosine-protein kinase erbB-3 [KO:K05084] [EC:2.7.10.1]
113266525  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
113253564  TP63; tumor protein 63 isoform X1 [KO:K10149]
113263391  ZEB2; zinc finger E-box-binding homeobox 2 isoform X1 [KO:K23560]
113267961  FSCN1; fascin [KO:K23551]
113256910  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
113250742  HOXD10; homeobox protein Hox-D10 [KO:K09295]
113259157  DDIT4; DNA damage-inducible transcript 4 protein [KO:K08270]
113242043  BMF; LOW QUALITY PROTEIN: bcl-2-modifying factor [KO:K17460]
113243596  PAK4; serine/threonine-protein kinase PAK 4 [KO:K05734] [EC:2.7.11.1]
113258671  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
113251221  SLC7A1; high affinity cationic amino acid transporter 1 [KO:K13863]
113264054  CCNG1; cyclin-G1 isoform X1 [KO:K10145]
113256008  HMOX1; heme oxygenase 1 isoform X1 [KO:K00510] [EC:1.14.14.18]
113268477  STMN1; stathmin [KO:K04381]
113265422  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
113252726  MYC; myc proto-oncogene protein [KO:K04377]
113262259  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
113257418  GTPase HRas-like [KO:K02833]
113244394  NRAS; GTPase NRas [KO:K07828]
113242975  DNMT1; DNA (cytosine-5)-methyltransferase 1 isoform X1 [KO:K00558] [EC:2.1.1.37]
113254991  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
113242735  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
113250390  IRS1; insulin receptor substrate 1 [KO:K16172]
113256705  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
113254730  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
113255266  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
113271274  MAPK7; mitogen-activated protein kinase 7 [KO:K04464] [EC:2.7.11.24]
113254799  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
113270537  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113253989  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
113269808  HNRNPK; heterogeneous nuclear ribonucleoprotein K isoform X1 [KO:K12886]
113260457  RECK; reversion-inducing cysteine-rich protein with Kazal motifs isoform X1 [KO:K17461]
113264513  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
113251536  IRS2; insulin receptor substrate 2 [KO:K07187]
113248585  neurogenic locus notch homolog protein 1 [KO:K02599]
113248639  neurogenic locus notch homolog protein 1-like [KO:K02599]
113244432  NOTCH2; neurogenic locus notch homolog protein 2 [KO:K20994]
113248714  NOTCH3; neurogenic locus notch homolog protein 3 isoform X1 [KO:K20995]
113243767  NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
113241342  BMI1; polycomb complex protein BMI-1 isoform X1 [KO:K11459]
113252967  MMP16; matrix metalloproteinase-16 [KO:K07996] [EC:3.4.24.-]
113260096  ATM; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
113270798  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]
113265043  CD44; CD44 antigen isoform X1 [KO:K06256]
113267305  DICER1; endoribonuclease Dicer [KO:K11592] [EC:3.1.26.-]
113269945  FZD3; frizzled-3 isoform X1 [KO:K02329]
113257516  ITGA5; integrin alpha-5 isoform X1 [KO:K06484]
113260084  RDX; radixin isoform X1 [KO:K05762]
113256876  RHOA; transforming protein RhoA [KO:K04513]
113259193  PLAU; urokinase-type plasminogen activator [KO:K01348] [EC:3.4.21.73]
113243812  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
113252835  ZFPM2; zinc finger protein ZFPM2 isoform X1 [KO:K17442]
113265309  ITGB3; integrin beta-3 [KO:K06493]
113245137  UBE2I; SUMO-conjugating enzyme UBC9 [KO:K10577]
113264517  SOX4; transcription factor SOX-4 [KO:K23581]
113262587  TNN; tenascin-N [KO:K06252]
113243732  TNXB; LOW QUALITY PROTEIN: tenascin-X [KO:K06252]
113262794  TNR; tenascin-R [KO:K06252]
113266339  TNC; tenascin isoform X1 [KO:K06252]
113259495  ABCB1; multidrug resistance protein 1 isoform X1 [KO:K05658] [EC:7.6.2.2]
113270755  ABCC1; multidrug resistance-associated protein 1 isoform X1 [KO:K05665] [EC:7.6.2.3]
113265384  BRCA1; breast cancer type 1 susceptibility protein [KO:K10605] [EC:2.3.2.27]
113243864  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
113245152  EFNA3; ephrin-A3 [KO:K05462]
113255018  EFNA5; ephrin-A5 isoform X1 [KO:K05462]
113245285  EFNA1; ephrin-A1 [KO:K05462]
113245292  EFNA4; ephrin-A4 [KO:K05462]
113242727  EFNA2; ephrin-A2 isoform X1 [KO:K05462]
113242050  THBS1; thrombospondin-1 [KO:K16857]
113265595  IGF2BP1; LOW QUALITY PROTEIN: insulin-like growth factor 2 mRNA-binding protein 1 [KO:K17391]
113253761  TRIM71; E3 ubiquitin-protein ligase TRIM71 [KO:K12035] [EC:2.3.2.27]
113263101  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
113245546  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
113262761  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
113267646  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
113247020  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
113265250  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
113267584  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
113247385  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
113244637  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
113245744  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
113267361  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
113271152  TP53; cellular tumor antigen p53 [KO:K04451]
113256295  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
113242500  MDM4; protein Mdm4 isoform X1 [KO:K10127]
113262493  PDGFRA; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
113258609  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
113252535  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
113257190  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
113240885  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
113242822  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
113266205  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
113241630  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
113245295  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
113248512  platelet-derived growth factor subunit A isoform X1 [KO:K04359]
113248525  platelet-derived growth factor subunit A isoform X1 [KO:K04359]
113269597  SHC4; SHC-transforming protein 4 [KO:K17449]
113241764  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
113263944  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
113260575  tumor suppressor ARF-like isoform X1 [KO:K06621]
113258272  E2F1; transcription factor E2F1 [KO:K17454]
113268523  E2F2; transcription factor E2F2 [KO:K09389]
113242278  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
113264709  MARCKS; myristoylated alanine-rich C-kinase substrate [KO:K12561]
113250576  BMPR2; bone morphogenetic protein receptor type-2 [KO:K04671] [EC:2.7.11.30]
113264707  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
113268357  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
113241452  EZH2; histone-lysine N-methyltransferase EZH2 isoform X1 [KO:K11430] [EC:2.1.1.356]
113256415  GLS2; glutaminase liver isoform, mitochondrial [KO:K01425] [EC:3.5.1.2]
113250653  GLS; glutaminase kidney isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
113259105  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
113265670  WNT3; proto-oncogene Wnt-3 [KO:K00312]
113247468  WNT3A; protein Wnt-3a [KO:K00312]
113244138  CDCA5; sororin [KO:K17390]
113240920  KIF23; kinesin-like protein KIF23 isoform X1 [KO:K17387]
113253267  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
113246159  PRKCE; protein kinase C epsilon type [KO:K18050] [EC:2.7.11.13]
113242479  SLC45A3; solute carrier family 45 member 3 [KO:K15379]
113241367  VIM; vimentin [KO:K07606]
Reference
  Authors
Lee YS, Dutta A
  Title
MicroRNAs in cancer.
  Journal
Annu Rev Pathol 4:199-227 (2009)
DOI:10.1146/annurev.pathol.4.110807.092222
Reference
  Authors
Babashah S, Soleimani M
  Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
  Journal
Eur J Cancer 47:1127-37 (2011)
DOI:10.1016/j.ejca.2011.02.008
Reference
  Authors
Garzon R, Calin GA, Croce CM
  Title
MicroRNAs in Cancer.
  Journal
Annu Rev Med 60:167-79 (2009)
DOI:10.1146/annurev.med.59.053006.104707
Reference
  Authors
Chen PS, Su JL, Hung MC
  Title
Dysregulation of microRNAs in cancer.
  Journal
J Biomed Sci 19:90 (2012)
DOI:10.1186/1423-0127-19-90
Reference
  Authors
Ling H, Zhang W, Calin GA
  Title
Principles of microRNA involvement in human cancers.
  Journal
Chin J Cancer 30:739-48 (2011)
DOI:10.5732/cjc.011.10243
Reference
  Authors
Iorio MV, Croce CM
  Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
  Journal
EMBO Mol Med 4:143-59 (2012)
DOI:10.1002/emmm.201100209
Reference
  Authors
Sayed D, Abdellatif M
  Title
MicroRNAs in development and disease.
  Journal
Physiol Rev 91:827-87 (2011)
DOI:10.1152/physrev.00006.2010
Reference
  Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
  Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
  Journal
Exp Biol Med (Maywood) 237:227-35 (2012)
DOI:10.1258/ebm.2011.011192
Reference
  Authors
Song JH, Meltzer SJ
  Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
  Journal
Gastroenterology 143:35-47.e2 (2012)
DOI:10.1053/j.gastro.2012.05.003
Reference
  Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
  Title
MiRNA s in oesophageal squamous cancer.
  Journal
Neth J Med 71:69-75 (2013)
Reference
  Authors
Kan T, Meltzer SJ
  Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
  Journal
Curr Opin Pharmacol 9:727-32 (2009)
DOI:10.1016/j.coph.2009.08.009
Reference
  Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
  Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
  Journal
World J Gastroenterol 16:531-7 (2010)
DOI:10.3748/wjg.v16.i5.531
Reference
  Authors
Song S, Ajani JA
  Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
  Journal
Nat Rev Gastroenterol Hepatol 10:109-18 (2013)
DOI:10.1038/nrgastro.2012.210
Reference
  Authors
Liu WH, Yeh SH, Chen PJ
  Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
  Journal
Biochim Biophys Acta 1809:678-85 (2011)
DOI:10.1016/j.bbagrm.2011.04.008
Reference
  Authors
Hrasovec S, Glavac D
  Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
  Journal
Front Genet 3:180 (2012)
DOI:10.3389/fgene.2012.00180
Reference
  Authors
Liu H
  Title
MicroRNAs in breast cancer initiation and progression.
  Journal
Cell Mol Life Sci 69:3587-99 (2012)
DOI:10.1007/s00018-012-1128-9
Reference
  Authors
Li SD, Zhang JR, Wang YQ, Wan XP
  Title
The role of microRNAs in ovarian cancer initiation and progression.
  Journal
J Cell Mol Med 14:2240-9 (2010)
DOI:10.1111/j.1582-4934.2010.01058.x
Reference
  Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
  Title
Characteristic patterns of microRNA expression in human bladder cancer.
  Journal
Front Genet 3:310 (2012)
DOI:10.3389/fgene.2012.00310
Reference
  Authors
Saini S, Majid S, Dahiya R
  Title
Diet, microRNAs and prostate cancer.
  Journal
Pharm Res 27:1014-26 (2010)
DOI:10.1007/s11095-010-0086-x
Related
pathway
uah05210  Colorectal cancer
uah05214  Glioma
uah05215  Prostate cancer
uah05219  Bladder cancer
uah05222  Small cell lung cancer
uah05223  Non-small cell lung cancer
KO pathway
ko05206   
LinkDB

DBGET integrated database retrieval system